YAR Yara International ASA

Program for the publication of Yara International ASA second quarter results 2020

Program for the publication of Yara International ASA second quarter results 2020

The Yara International ASA second quarter 2020 report and presentation will be published on Friday 17 July 2020 at 08:00 CEST.



An on-line presentation and Q&A session will be held at 12:00 CEST, hosted by Yara President and CEO Svein Tore Holsether, CFO Lars Røsæg, EVP Global Plants & Operational Excellence Pål Hestad and EVP Farming Solutions Terje Knutsen. The presentation will be held in English.



The report, presentation and webcast will be available at the above mentioned times at:







Yours faithfully

for Yara International ASA



Thor Giæver

Head of Investor Relations





About Yara



Yara grows knowledge to responsibly feed the world and protect the planet. Supporting our vision of a world without hunger, we pursue a strategy of sustainable value growth, promoting climate-friendly and high-yielding crop nutrition solutions for the world’s farming community and food industry.



Yara’s ambition is to be the Crop Nutrition Company for the Future. We are committed to creating value for our customers, shareholders and society at large, as we work to develop a more sustainable food value chain. To achieve our ambition, we have taken the lead in developing digital farming tools for precision farming, and work closely with partners throughout the food value chain to improve the efficiency and sustainability of agriculture and food production.



Founded in 1905 to solve the emerging famine in Europe, Yara has established a unique position as the industry’s only global crop nutrition company. With our integrated business model and a worldwide presence of around 16,000 employees and operations in over 60 countries, we offer a proven track record of responsible and reliable returns.
In 2019, Yara reported revenues of USD 12.9 billion.







This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

EN
15/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Yara International ASA

Yara International ASA: 2 directors

Two Directors at Yara International ASA bought/maiden bought 2,337 shares at between 315.000NOK and 316.600NOK. The significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the compa...

 PRESS RELEASE

Yara International ASA - Mandatory notifications of trade

Yara International ASA - Mandatory notifications of trade Yara Board member Jannicke Hilland has purchased a total of 1,587 Yara shares on Friday, 26 April 2024 at an average price of NOK 315 per share. Following this purchase, Jannicke Hilland owns a total of 1,587 shares in Yara international ASA. Yara Board member Therese Log Bergjord has purchased a total of 750 Yara shares on Friday, 26 April 2024 at an average price of NOK 316.6 per share. Following this purchase, Therese Log Bergjord owns a total of 750 shares in Yara International ASA. Details of the transactions can be fo...

ABGSC Chemicals Research ... (+3)
  • ABGSC Chemicals Research
  • Bengt Jonassen
  • Martin Melbye

It does not add up - Down to HOLD (Buy)

Price headwinds stronger than expected. Slashing estimates for 2024-26e. ~7% ATRoCE suggests EV/CE ~1x is fair - HOLD (Buy) TP 325.

Niclas Gehin
  • Niclas Gehin

Yara (Buy, TP: NOK425.00) - Q1 disappoints the market

While the Q1 results disappointed the market, we consider a ~USD70m–120m EBITDA miss to be within a normal standard deviation and have made only minor estimate changes. Yara’s share price in dollar terms (USD29) is among its lowest since 2010, yet consensus earnings forecasts are at normalised levels. We believe this reflects investor fears it will act irrationally with its capex (NIBD/EBITDA of 2.3x does not give it the muscle to carry out the announced blue ammonia investments). While we hear ...

ABGSC Chemicals Research ... (+3)
  • ABGSC Chemicals Research
  • Bengt Jonassen
  • Martin Melbye

ResearchPool Subscriptions

Get the most out of your insights

Get in touch